We confirmed the essential role of MerTK with subcutaneous and intracranial models of glioma utilizing lines that had genetic inhibition of MerTK, this allows for both exclusive targeting as well as more thorough inhibition of signaling. The gene discussed is MERTK; the disease is glioma.